APA (7th ed.) Citation

SG, P., CK, K., I, K., D, V., A, S., A, G., . . . V, P. (2018). The outcome of patients with high-risk MDS achieving stable disease after treatment with 5-azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group. Hematological oncology, 36(4), 693. https://doi.org/10.1002/hon.2551

Chicago Style (17th ed.) Citation

SG, Papageorgiou, et al. "The Outcome of Patients with High-risk MDS Achieving Stable Disease After Treatment with 5-azacytidine: A Retrospective Analysis of the Hellenic (Greek) MDS Study Group." Hematological Oncology 36, no. 4 (2018): 693. https://doi.org/10.1002/hon.2551.

MLA (9th ed.) Citation

SG, Papageorgiou, et al. "The Outcome of Patients with High-risk MDS Achieving Stable Disease After Treatment with 5-azacytidine: A Retrospective Analysis of the Hellenic (Greek) MDS Study Group." Hematological Oncology, vol. 36, no. 4, 2018, p. 693, https://doi.org/10.1002/hon.2551.